<DOC>
	<DOCNO>NCT00551408</DOCNO>
	<brief_summary>Endothelial dysfunction ultimately represent imbalance magnitude injury capacity repair . Current evidence establish endothelial progenitor cell ( EPC ) participate several model vascular disease acute coronary syndrome , stroke , diabetes , peripheral artery disease , etc . However EPC set PAH le well establish . The target study demonstrate number EPC increase mexican population patient PAH .</brief_summary>
	<brief_title>Endothelial Progenitor Cells Pulmonary Idiopathic Arterial Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<criteria>Patients include study The WHO functional class II III , mean pulmonary artery pressure &gt; 30 mm Hg right heart catheterization . The ability walk &gt; 50 standardize 6min walk test . Pulmonary hypertension result heart disease , pulmonary disease , sleepassociated disorder , chronic thromboembolic disease , autoimmune collagen vascular disease , HIV infection , liver disease , major bleed require blood transfusion , renal dysfunction , evidence malignant disease exclude .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2007</verification_date>
</DOC>